ADD ANI AS A TRUSTED SOURCE
googleads
Menu

      
      Bharat Biotech to advance development of GSK's Shigella vaccine

Bharat Biotech to advance development of GSK's Shigella vaccine

Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and manufacturing on Thursday...

      
      'iNCOVACC, testimony to innovative zeal of our scientists'

'iNCOVACC, testimony to innovative zeal of our scientists'

Mandaviya unveiled the Inncovacc- the first India-made nasal Covid-19 vaccine today in the presence of Union...


      
      iNCOVACC world's first intra-nasal vaccine to receive approval

iNCOVACC world's first intra-nasal vaccine to receive approval

iNCOVACC, on Tuesday, became the world's first intra-nasal vaccine to receive both Primary series and Heterologous...

      
      DCGI's SEC to hold discussion on

DCGI's SEC to hold discussion on "five arms" booster dose

DCGI has already given emergency use authorization (EUA) to BBIL for the intranasal vaccine. BBIL had in...


      
      Nigeria introduces Bharat Biotech's Rotavac vaccine for children

Nigeria introduces Bharat Biotech's Rotavac vaccine for children

Hyderabad (Telangana) [India], August 24 (ANI): Bharat Biotech International Limited (BBIL), the Indian vaccines and...

      
      Covaxin safe for children aged 2-18 years, says Bharat Biotech

Covaxin safe for children aged 2-18 years, says Bharat Biotech

Hyderabad (Telangana) [India], June 17 (ANI): Bharat Biotech International Limited (BBIL) on Thursday announced that...

      
      Ocugen to commercialize Covaxin in Mexico

Ocugen to commercialize Covaxin in Mexico

Malvern (Pennsylvania) [US]/ Hyderabad (Telangana) [India], April 18 (ANI): Biotechnology company Ocugen and Bharat...

      
      Indian Immunologicals hands over first lot of Covaxin drug...

Indian Immunologicals hands over first lot of Covaxin drug...

Hyderabad (Telangana) [India], August 13 (ANI): In order to augment the Covid-19 vaccine production capacity in our...

      
      COVAXIN shows 81 pc efficiency in phase three trials, says ICMR

COVAXIN shows 81 pc efficiency in phase three trials, says ICMR

New Delhi [India], March 3 (ANI): Phase three results of the COVAXIN, a vaccine against COVID-19 which has been...


      
      'A powerful example for all Indians': Bharat Biotech after PM...

'A powerful example for all Indians': Bharat Biotech after PM...

Hyderabad (Telangana) [India], March 1 (ANI): Bharat Biotech International Limited (BBIL), the Indian vaccines and...

      
      Bharat Biotech dispatches COVID-19 vaccine Covaxin to 11...

Bharat Biotech dispatches COVID-19 vaccine Covaxin to 11...

Hyderabad (Telangana) [India], January 13 (ANI): The Bharat Biotech International Limited (BBIL) has announced...


      
      PM Modi visits Bharat Biotech vaccine facility, Zydus Biotech Park

PM Modi visits Bharat Biotech vaccine facility, Zydus Biotech Park

Hyderabad (Telangana) [India], November 28 (ANI): Prime Minister Narendra Modi on Saturday visited the...

Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.